These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6449820

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Muscle relaxants and reversal agents.
    Van Sickel AD, Spadaccia K.
    Crit Care Nurs Clin North Am; 1991 Mar; 3(1):151-8. PubMed ID: 2043325
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages].
    Schuh FT.
    Klin Anasthesiol Intensivther; 1980 Mar; 22():158-74. PubMed ID: 6108384
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
    Lien CA.
    Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
    [No Abstract] [Full Text] [Related]

  • 8. Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade.
    Fink H, Hollmann MW.
    Minerva Anestesiol; 2012 Apr; 78(4):473-82. PubMed ID: 22454044
    [Abstract] [Full Text] [Related]

  • 9. Preclinical pharmacology of sugammadex.
    Bom A, Hope F, Rutherford S, Thomson K.
    J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of muscle relaxants.
    Glass PM.
    J Post Anesth Nurs; 1989 Apr; 4(2):112-5. PubMed ID: 2522545
    [No Abstract] [Full Text] [Related]

  • 13. Absence of "recurarization" in patients with demonstrated prolonged neuromuscular block.
    Lee C, Mok MS, Barnes A, Katz RL.
    Br J Anaesth; 1977 May; 49(5):485-9. PubMed ID: 861117
    [Abstract] [Full Text] [Related]

  • 14. Effects of acetylcholinesterase inhibitor therapy for Alzheimer's disease on neuromuscular block.
    Baruah J, Easby J, Kessell G.
    Br J Anaesth; 2008 Mar; 100(3):420. PubMed ID: 18276655
    [No Abstract] [Full Text] [Related]

  • 15. Antagonism of neuromuscular blockade.
    Cronnelly R, Morris RB.
    Br J Anaesth; 1982 Feb; 54(2):183-94. PubMed ID: 7037027
    [No Abstract] [Full Text] [Related]

  • 16. Is it always necessary to antagonize residual neuromuscular block? Do children differ from adults?
    Hunter JM.
    Br J Anaesth; 1996 Dec; 77(6):707-9. PubMed ID: 9014619
    [No Abstract] [Full Text] [Related]

  • 17. Practical points in understanding neuromuscular blockade.
    Steckbar T.
    J Post Anesth Nurs; 1990 Oct; 5(5):350-3. PubMed ID: 2213630
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.